Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Qiagen N.V.    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Qiagen N.V.
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid).

In 2019, the group developed more than 500 consumable products and automated solutions through its 35 production sites worldwide.

Net sales break down geographically as follows: the United States (43.5%), America (3.8%), Europe/Middle East/Africa (31.9%) and other (20.8%).

Number of employees : 5 096 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Consumables1,31587.6%1,35488.7% +2.94%
Instruments186.3912.4%172.2811.3% -7.57%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
United States632.6642.1%663.8743.5% +4.93%
Europe, Middle East and Africa474.4031.6%471.6830.9% -0.57%
Asia Pacific, Japan and Rest of World318.5321.2%316.9620.8% -0.49%
Other Americas60.364%58.123.8% -3.71%
Netherlands15.901.1%15.801% -0.63%
Managers
NameAgeSinceTitle
Thierry Bernard542019Chief Executive Officer
Lawrence Rosen622020Chairman-Supervisory Board
Barthold Piening612018Senior Vice President & Head-Global Operations
Roland Sackers502004Chief Financial Officer & Managing Director
Metin Colpan, Dr.662004Independent Member-Supervisory Board
Elizabeth E. Tallett702011Member-Supervisory Board
Stéphane Bancel462013Independent Member-Supervisory Board
Elaine R. Mardis, Dr.562014Independent Member-Supervisory Board
Ross L. Levine, Dr.472016Independent Member-Supervisory Board
Thomas Neidert-2008Vice President-Global Treasury
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 230,829,000 214,352,384 92.9% 2,080,000 0.9% 92.9%
Shareholders
NameEquities%
Davidson Kempner Capital Management LP 18,253,052 8.00%
PRIMECAP Management Co. 13,133,386 5.76%
Credit Suisse Securities (USA) LLC (Broker) 10,289,288 4.51%
Citigroup Global Markets, Inc. (Investment Management) 10,195,541 4.47%
Massachusetts Financial Services Co. 9,140,412 4.01%
Farallon Capital Management LLC 7,338,817 3.22%
Baillie Gifford & Co. 7,169,829 3.14%
PSquared Asset Management AG 6,757,053 2.96%
The Vanguard Group, Inc. 6,383,439 2.80%
Norges Bank Investment Management 5,223,487 2.29%
Markets and indexes
- Frankfurt
- Prime Standard
- MDAX / PEA
Stock Exchange Codes
- Bloomberg Code :  QIA:GR
- Reuters Code :  QIA.DE
- Datastream Code :  
Company contact information
Qiagen N.V.
82 Hulsterweg
NL-5912 PL Venlo
Netherlands

Phone : +31 77 355 6600
Fax : +31 77 355 6658
Internet : http://www.qiagen.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Qiagen N.V.
Sector Biotechnology & Medical Research - NEC